Clinuvel (CUV.AX) traded down -1.54 % during a 24 hours period ending at 01:47 PM Central Europe on Tuesday 27th. One Clinuvel stock can currently be bought for about AUD 7.2 on popular exchanges. Current supply of Clinuvel stocks is 49.9 mn. Clinuvel has a current market capitalization of AUD 350 mn and approximately AUD 1.5 mn worth of Clinuvel was traded on exchanges in the last 24 hours. Since last month end, Clinuvel has traded -14.2 % down. Simple moving average of last 200 days is at AUD 9.56. The highest price of past 52 weeks was recorded at AUD 13.48 on 01/12/2026. 52 weeks low was at AUD 6.62 on 10/20/2026.
Here is how related stocks have performed in the past 24 hours:
Santana Minerals (SMI.AX) traded up 3.85 % and now trades at AUD 0.42. Santana Minerals has a market capitalisation of AUD 392.3 mn.
Unico Silver (USL.AX) traded up 1.8 % and now trades at AUD 0.58. Unico Silver has a market capitalisation of AUD 407.5 mn.
K & S (KSC.AX) traded up 0.33 % and now trades at AUD 3.02. K & S has a market capitalisation of AUD 413.3 mn. Current price/earnings ratio for K & S is 18.19.
Accent (AX1.AX) traded up 0.76 % and now trades at AUD 0.66. Current market capitalisation for Accent is AUD 396.8 mn.
Vysarn (VYS.AX) traded up 2.99 % and now trades at AUD 0.69. Current market capitalisation for Vysarn is AUD 395.1 mn. Vysarn has a current price to earnings ratio of 37.14.
About Clinuvel
Clinuvel Pharmaceuticals Ltd. is an Australian biopharmaceutical company that specializes in developing dermatology pharmaceutical products for a range of UV-related skin disorders. The company’s work aims at preventing the symptoms of diseases related to harmful UV radiation.